Fibromyalgia clinical design
Executive Summary
The arthritis committee will meet June 23 to discuss clinical trial design for therapies intended to treat fibromyalgia, including important disease endpoints. Pfizer has been conducting studies of its Neurontin successor agent pregabalin in fibromyalgia (1"The Pink Sheet" Nov. 4, 2002, p. 8). The meeting will begin at 8 a.m. on both days at the Holiday Inn in Bethesda, Md. [For 2webcasts, live video or videotapes of these and other meetings, go to FDAAdvisoryCommittee.com]...